Researchers have proven the efficacy of vaccines they created to prevent the disfiguring skin illness leishmaniasis in animal experiments, and the most promising candidate is currently undergoing preparation for a Phase 1 human trial.
Washington [US], January 22 (ANI): A recent study led by a team of researchers at Northwestern University has discovered a technique to help make immunomodulation more effective. The method used nanocarriers to re-engineer the commonly used immunosuppressant rapamycin.
Evanston (Illinois) [US], January 18 (ANI): A team of researchers at Northwestern University have discovered a technique to help make immunomodulation more effective. The method used nanocarriers to re-engineer the commonly used immunosuppressant rapamycin.